Canada markets closed

DIAGNOS Inc. (ADK.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3100+0.0050 (+1.64%)
At close: 03:11PM EDT
Full screen
Previous Close0.3050
Open0.3150
Bid0.3050 x 0
Ask0.3100 x 0
Day's Range0.3050 - 0.3150
52 Week Range0.2300 - 0.5900
Volume19,300
Avg. Volume81,366
Market Cap24.11M
Beta (5Y Monthly)-0.43
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateJul 11, 2024 - Jul 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.00
  • GlobeNewswire

    DIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreement

    BROSSARD, Quebec, May 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its FLAIRE platform based on Artificial Intelligence (AI), is thrilled to announce the renewal of its distribution agreement with Labtician, a leading provider of medical supplies and equipment, for the Canadian territory. This renewed distribution agreement comes after the final integration of DIAGNOS’

  • GlobeNewswire

    DIAGNOS Announces Closing of First Tranche of Private Placement

    BROSSARD, Quebec, May 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the closing of a first tranche of 1,125,000 units (each a “Unit”) issued at a price of $0.28 per Unit, for gross proceeds of $315,000, as part of a non-brokered private placement of up to 5,357,142 units, for gross proceeds of up to $1,500,0

  • GlobeNewswire

    DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024

    BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, in collaboration with ETS, École de Technologie Supérieure, is proud to announce its participation in the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting. DIAGNOS will showcase its latest advancements in artificial intelligence applied to retinal imagi